Intended Use

Indicated for use by adult patients (22 years and older) who have been diagnosed with, or are susceptible to developing, atrial fibrillation enabling them to monitor and record their heart rhythms. Intended to record, store, transfer, and display single-channel ECG rhythms in professional healthcare facility environments while worn as a wrist watch.

Technology

Miniaturized physiological data monitoring device including a wearable watch with two dedicated sensing electrodes for ECG measurement and an optical sensor for PPG waveform collection. Data is transferred securely to a cloud server via a cradle and a Study Hub device, and accessed by healthcare providers via a web portal. Uses proprietary hardware and firmware for data acquisition and irregular pulse detection.

Performance

Bench testing validated performance of PPG sensor, battery life, firmware including irregular pulse monitoring feature, following predicate device verification. Human factors studies demonstrated effective use of instructions and user interface. Clinical testing showed sensitivity of 85% and specificity of 96% for irregular pulse detection in patients with atrial fibrillation, meeting pre-specified endpoints and confirming substantial equivalence to predicate devices.

Predicate Devices

No predicate devices specified

Device Timeline

  • 1

    Submission

    9/4/2019

    4 months
  • 2

    FDA Approval

    1/17/2020

Other devices from Verily Life Sciences LLC

Ready to Sharpen Your Edge?

Join hundreds of your peers who rely on RadAI Slice. Get the essential weekly briefing that empowers you to navigate the future of radiology.

We respect your privacy. Unsubscribe at any time.